Prescription Drug News and Research

RSS

Consumers economizing on healthcare in ways that might be dangerous: Poll

More than two-thirds (69%) of Americans currently taking a prescription drug say drug makers have too much influence on doctors' prescribing decisions and half say that doctors are too eager to prescribe a drug when other non-drug options are available for managing a condition. Those are just some of the concerns raised by Americans in a new prescription drug poll by the Consumer Reports National Research Center. More information about the poll is available online at www.consumerreportsenespanol.org.

24 Aug 2010

Catalyst Health Solutions named on 2010 Fortune 100 Fastest-Growing Companies List

Catalyst Health Solutions, Inc., announced today that it was named to the 2010 Fortune 100 Fastest-Growing Companies List. Catalyst has achieved this recognition for three consecutive years and four times in six years. The Company was also named on Fortune's Fastest-Growing All-Stars List.

21 Aug 2010

FDA extends review on Acetadote for non-acetaminophen acute liver failure

Cumberland Pharmaceuticals Inc. today announced the U.S. Food and Drug Administration (FDA) has extended its review of the supplemental new drug application (sNDA) for the use of Acetadote® (acetylcysteine) Injection in patients with non-acetaminophen acute liver failure.

21 Aug 2010

Medicare Part D cost estimate drops 41%: PCMA

The Pharmaceutical Care Management Association (PCMA) issued the following statement on research cited by the Centers for Medicare & Medicaid Services (CMS) that found the most recent 10-year cost estimate for Medicare Part D came in at $373 billion, a 41 percent drop from the initial cost estimate of $634 billion for 2004-2013

20 Aug 2010

CMS: Seniors will see modest increase in Medicare drug premiums but improved benefits

The Associated Press: "Seniors will see a modest increase in their Medicare prescription premiums next year but benefits will also improve, federal health officials said Wednesday. The average monthly premium charged by Medicare drug plans for standard coverage will rise to an estimated $30 in 2011, an increase of $1 over 2010..." But, the AP notes that "Medicare prescription plans vary widely in costs and benefits.

20 Aug 2010

FDA grants priority review designation of BENLYSTA for systemic lupus erythematosus treatment

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has granted a priority review designation to BENLYSTA (belimumab) as a potential treatment for systemic lupus erythematosus.

20 Aug 2010

Pharmacies in Massachusetts to make available lock boxes for sale

On August 9, 2010 Massachusetts passed Chapter 283 of the Acts of 2010, adding Safeguards to the Prescription Monitoring Program and furthering Substance Abuse Education and Prevention. Section 11 of the act requires all pharmacies in Massachusetts that dispense schedule II, III, IV, or V prescription drugs to make available lock boxes for sale at each location.

18 Aug 2010

Cigna lobbies to define medical loss ratio on insurers' terms

Cigna has become a player in the insurance industry's lobbying on what should count as medical care under new rules governing health care spending, Kaiser Health News and McClatchy report. "The insurer has stayed in step with larger rivals such as Aetna and WellPoint in an often contentious dialogue with the National Association of Insurance Commissioners — a network of state regulators that's been charged with advising federal officials on implementing the health care law.

18 Aug 2010

Pharmacy drug information confusing or lacking, study says

NPR: The Food and Drug Administration is about to make changes to drug information — often filled with technical medical jargon — to help consumers understand the risks and benefits of the drugs they take. "University of Florida professor Carole Kimberlin worked with colleagues to sample leaflets from some 400 pharmacies across the country recently at the request of the FDA. They found wide differences. 'Some of them were as little as 30 words, while others were over 2,500 words,' she says.

18 Aug 2010

Lotus Pharmaceuticals second-quarter net income increases 32% to $6.3 million

Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China, reported today its financial results for the quarter and six months ended June 30, 2010.

16 Aug 2010

Research Roundup: Disabled Medicare Enrollees' challenges; Increasing ER visits; costs/benefits of Part D

Health Affairs: Medicare Doesn't Work As Well For Younger, Disabled Beneficiaries As It Does For Older Enrollees - This paper examines "how well Medicare works for [the 8 million] nonelderly disabled beneficiaries compared to the elderly, based on findings from a nationally representative survey of noninstitutionalized Medicare beneficiaries conducted in 2008 by the Kaiser Family Foundation."

16 Aug 2010

Five tips for seniors researching MA or Medigap plan options

Health Plan One, a general agent in the online health insurance market, seeks to guide seniors to choose carefully when selecting their Medicare Advantage or Medicare supplement plan. Seniors will have only one opportunity to make changes to their Medicare plans during the Annual Enrollment Period this November 15 through December 31.

13 Aug 2010

Insurers, small businesses and ER care all affected by overhaul

News outlets consider the impact of health reform on insurers — who are seeking flexibility on mandates — as well as changes to premiums, small businesses and emergency room care.

13 Aug 2010

First Edition: August 12, 2010

Some of today's headlines highlight how the new health reform law is playing beyond Washington, D.C.'s beltway.

12 Aug 2010

Bristol-Myers Squibb, ACTF announce enhanced agreement to support ADAPs

Bristol-Myers Squibb Company and the ADAP Crisis Task Force today announced an enhanced agreement to support the efforts of AIDS Drug Assistance Programs to provide antiretroviral medicines to people living with HIV and AIDS. Building on an agreement signed in March of 2010, today's announcement marks a multi-year enhancement to assist ADAPs in meeting the challenges of increasing patient case loads and strained government funding.

12 Aug 2010

FDA advisory committee votes in favor of investigational anti-epileptic drug ezogabine

GlaxoSmithKline and Valeant Pharmaceuticals International announced today that a U.S. Food and Drug Administration advisory committee voted unanimously that clinical studies had provided substantial evidence of the effectiveness of ezogabine as adjunctive treatment for adults with partial-onset seizures.

12 Aug 2010

More Medicare Part D checks in the mail

The Department of Health and Human Services has mailed out a third round of $250 checks to help seniors who enter the Medicare Part D coverage pay gap for prescription drugs, WCAX [in Vermont] reports. "The one-time payment aims to close a gap in coverage for prescription medication. The rebates will go to about 9,000 Vermonters whose out-of-pocket expenses already total more than $940 for the year" (8/11).

12 Aug 2010

Third round of tax-free $250 rebate checks mailed to eligible Medicare beneficiaries

Today, U.S. Department of Health and Human Services Secretary Kathleen Sebelius announced that the third round of one-time, tax-free $250 rebate checks have been mailed to eligible Medicare beneficiaries whose drug costs are so high they have reached the Medicare Part D prescription drug coverage gap known as the "donut hole."

11 Aug 2010

U.S. Senators introduce legislation to encourage R&D aimed at neglected pediatric diseases

"New bipartisan legislation was introduced in the U.S. Senate last week which seeks to encourage innovative [research and development] R&D by drugmakers aimed at treating rare and neglected pediatric diseases," PharmaTimes reports.

11 Aug 2010

Education, changes in reimbursement practices can reduce inappropriate antibiotic usage: Study

Improved drug coverage under Medicare Part D has led to an increase in the use of antibiotics by seniors, particularly of brand-name and more expensive drugs, according to a University of Pittsburgh Graduate School of Public Health study. Published in the Aug. 23 issue of Archives of Internal Medicine and the first to explore spending on antibiotics under Medicare Part D, the study suggests recent changes in drug coverage improved the use of antibiotics for pneumonia, but could lead to unnecessary spending on expensive broad-spectrum antibiotics and the overuse of inappropriate antibiotics.

11 Aug 2010

Prescription Drug News and Research

Consumers economizing on healthcare in ways that might be dangerous: Poll

Catalyst Health Solutions named on 2010 Fortune 100 Fastest-Growing Companies List

FDA extends review on Acetadote for non-acetaminophen acute liver failure

Medicare Part D cost estimate drops 41%: PCMA

CMS: Seniors will see modest increase in Medicare drug premiums but improved benefits

FDA grants priority review designation of BENLYSTA for systemic lupus erythematosus treatment

Pharmacies in Massachusetts to make available lock boxes for sale

Cigna lobbies to define medical loss ratio on insurers' terms

Pharmacy drug information confusing or lacking, study says

Lotus Pharmaceuticals second-quarter net income increases 32% to $6.3 million

Research Roundup: Disabled Medicare Enrollees' challenges; Increasing ER visits; costs/benefits of Part D

Five tips for seniors researching MA or Medigap plan options

Insurers, small businesses and ER care all affected by overhaul

First Edition: August 12, 2010

Bristol-Myers Squibb, ACTF announce enhanced agreement to support ADAPs

FDA advisory committee votes in favor of investigational anti-epileptic drug ezogabine

More Medicare Part D checks in the mail

Third round of tax-free $250 rebate checks mailed to eligible Medicare beneficiaries

U.S. Senators introduce legislation to encourage R&D aimed at neglected pediatric diseases

Education, changes in reimbursement practices can reduce inappropriate antibiotic usage: Study

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News